The differential effects between stimulated cells from MS and controls may again be attributed to the known MS-associated polymorphisms in the IL-12 subunits, IL-12R, and IL-2R genes, as previously demonstrated for T cell-derived GM-CSF [22,32]. The gene discussed is IL2RA; the disease is myeloid sarcoma.